Iris Behrmann

14.4k citations
94 papers · 11.7k · 4 hit papers · h-index 46

Impact in

  • Immunology top 0.2%
    • interferon and immune responses
    • Immune Cell Function and Interaction
    • Immune Response and Inflammation
  • Oncology top 0.2%
    • Cytokine Signaling Pathways and Interactions

Papers in

    • Cytokine Signaling Pathways and Interactions 58
    • Protein Tyrosine Phosphatases 9
    • Melanoma and MAPK Pathways 8

Iris Behrmann

92 papers receiving 11.4k citations

Iris Behrmann's Hit Papers

Principles of interleukin (IL)-6-type cytokine signalling and its regulation 2003 · 2.6k citations
2.6k0+11+22Years since publication50010001.5k2.0k2.5k

Peers

Iris Behrmann
Comparison fields: 5 of 136
  • Immunology 4.0k
  • Oncology 4.6k
  • Cancer Research 1.7k
  • Molecular Biology 5.5k
  • Pharmacology 563
Replace Koichi Nakajima with:
Koichi Nakajima Japan
Fred Schaper Germany
Tracy A. Willson Australia
Jacqueline Bromberg United States
David A. Frank United States
Andrew C. Larner United States
Lawrence M. Pfeffer United States
Daniel E. Johnson United States
Chris Albanese United States
Richard Moriggl Austria
Iris Behrmann relative to Koichi Nakajima Japan Koichi Nakajima's profile →
Citations per field
00.5×2.7×
Koichi Nakajima · 1×
Citations per year

Countries citing papers authored by Iris Behrmann

Since Specialization
Citations

This map shows the geographic impact of Iris Behrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Behrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Behrmann more than expected).

Fields of papers citing papers by Iris Behrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Behrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Behrmann. The network helps show where Iris Behrmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Iris Behrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Behrmann Line = papers co-authored together Iris Behrmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
Hit paper breakdown →
20032586
2
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
Hit paper breakdown →
19981783
3
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
Hit paper breakdown →
19951700
4
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.
Hit paper breakdown →
1992746
5 1994273
6 2006208
7 1994201
8 2002187
9 2010186
10 2006179
11 2001160
12 2011157
13 1994143
14 1999118
15 2003117
16 2013101
17 201295
18 200288
19 200281
20 201081

About Iris Behrmann

Iris Behrmann is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pharmacology, having authored 94 papers that have together received 11.7k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (58 papers), interferon and immune responses (12 papers), Protein Tyrosine Phosphatases (9 papers), Pharmacological Effects of Natural Compounds (9 papers), Melanoma and MAPK Pathways (8 papers), Immune Cell Function and Interaction (8 papers), MicroRNA in disease regulation (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Immunology (4.0k citations), Oncology (4.6k citations), Cancer Research (1.7k citations), Molecular Biology (5.5k citations) and Pharmacology (563 citations). Iris Behrmann has collaborated with scholars based in Germany, Luxembourg and Belgium. Frequent co-authors include Peter C. Heinrich, Fred Schaper, Gerhard Müller‐Newen, Serge Haan, Heike M. Hermanns, Lutz Graeve, Peter H. Krammer, Michael Pawlita, Claude Haan and Marcus E. Peter. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, The Journal of Immunology, FEBS Letters and Journal of Cellular and Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact